恒瑞医药:H股股票于5月23日在香港联交所主板挂牌并上市交易

澎湃新闻
23 May

5月23日,江苏恒瑞医药股份有限公司公告,公司本次全球发售H股总数为224,519,800股(行使超额配售权之前),其中,香港公开发售48,271,800股,约占全球发售总数的21.5%(行使超额配售权之前);国际发售176,248,000股,约占全球发售总数的78.5%(行使超额配售权之前)。根据每股H股发售价44.05港元计算,经扣除全球发售相关承销佣金及其他估计费用后,并假设超额配售权未获...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10